Federal Ministry of Education and Research (BMBF)

• Research Building Multidimensional Trauma Sciences (MTW) (Funding according to article 91b GG; Speaker: Prof. Dr. M. Huber-Lang, Institute for Clinical and Experimental Trauma Immunology)
• NCT SouthWest, Site of the National Center for Tumor Diseases (NCT), Cooperation between Comprehensive Cancer Center Tübingen-Stuttgart and Comprehensive Cancer Center Ulm (Speaker: Prof. Dr. L. Zender, Department of Internal Medicine VIII, Tübingen University Hospital)
• Early Intervention at the Workplace (friaa) (Speaker: PD Dr. E. Rothermund, Prof. Dr. H. Gündel, K. Herrmann, Department of Psychosomatic Medicine and Psychotherapy)
• Evaluation of a Stress Management Intervention for Managers in Small and Medium Enterprises (KMU-GO!) (Speaker: Prof. Dr. H. Gündel, Department of Psychosomatic Medicine and Psychotherapy)
• Self-Injury: Treatment-Assessment-Recovery (STAR) (Speaker: Prof. Dr. P. Plener, Department of Child and Adolescent Psychiatry/Psychotherapy); ends December 31, 2022
• InnoSÜD Consortium of the Universities of Applied Sciences Biberach, Neu-Ulm and Ulm together with Ulm University (Speaker of the Pharmaceutical Biotechnology topic of Ulm University: Prof. Dr. S. Kochanek, Department of Gene Therapy); ends December 31, 2022
• Mental Health at the Workplace Hospital (SEEGEN) (Speaker: Prof. Dr. H. Gündel, Department of Psychosomatic Medicine and Psychotherapy); successfully concluded October 31, 2022
• Healthcare as a Public Space: Social Integration and Social Diversity in the Context of Access to Healthcare in Europe as part of the ERA-NET "HERA" (Speaker: Prof. Dr. F. Steger, Institute of the History, Philosophy and Ethics of Medicine); successfully concluded October 31, 2022

Federal Ministry of Defence (BMVg)

• Development of regenerative therapies for the treatment of tissue injuries; Cooperation with the Military Hospital Ulm (Speaker Prof. Dr. A. Ignatius, Institute of Orthopaedic Research and Biomechanics)

Innovation Fund of the Federal Joint Committee (G-BA) – Health Services Research

• IPS-Pilot – Integrierte Psychosoziale Versorgung in der Intensivmedizin: Partizipative Entwicklung und Pilotierung eines innovativen Versorgungsansatzes (Speaker: Prof. Dr. Harald Gündel, Department of Psychosomatic Medicine and Psychotherapy)
• EPPIK – Überprüfung der Eignung des ‚Plattformmodells‘ als Instrument zur Personalbemessung in psychiatrischen und psychosomatischen Kliniken (Speaker: Dr. Markus Kösters, Department of Psychiatry and Psychotherapy II)
• QualiPäd – Evaluation der Versorgungsqualität in der ambulanten Routineversorgung häufiger Erkrankungen des Kindes- und Jugendalters (Speaker: Prof. Dr. Dr. Christian Bachmann, Department of Child and Adolescent Psychiatry/Psychotherapy)
• EvaCoM – Evaluation des unfallchirurgisch-geriatrischen Co-Managements bei alterstraumatologischen Frakturen älterer Patientinnen und Patienten (Speaker: Prof. Dr. Dietrich Rothenbacher, Institute of Epidemiology and Medical Biometry)
• IVZ S3 – Implementierung der S3 Leitlinie Verhinderung von Zwang (Speaker: Prof. Dr. Tilman Steinert, Department of Psychiatry and Psychotherapy I – Weissenau); ends February 28, 2023
• TRADE – TRAnsport und DElir älterer Menschen (Speaker: Prof. Dr. Michael Denkinger, AGAPLESION Bethesda Hospital – Department of Geriatric Medicine of Ulm University); ends March 31, 2023
• LQM – Lebensqualitäts-Monitoring Online zur Versorgungsoptimierung herzkranker Kinder und Jugendlicher (Speaker: Prof. Dr. Jörg M. Fegert, Department of Child and Adolescent Psychiatry/Psychotherapy); successfully concluded June 30, 2022
• IMPPETUS – Implementierung der Patientenleitlinie Psychosoziale Therapien für Patienten mit schweren psychischen Erkrankungen (Speaker: Dr. Markus Kösters, Department of Psychiatry and Psychotherapy II); successfully concluded December 31, 2021

Framework Programme Horizon 2020

• Using Peer Support In Developing Empowering Mental Health Services (UPSIDES) (Speaker: Prof. Dr. B. Puschner, Department of Psychiatry and Psychotherapy II)

Graduate School:

• International Graduate School in Molecular Medicine Ulm (Board of Directors: Prof. Dr. B. Knöll [Chairman, Institute of Neurobiochemistry], Prof. Dr. M. Frick [Vice-Chairman, Institute of General Physiology], Prof. Dr. D. Rautenbach [Vice-President Career of Ulm University], PD Dr. M. Vujić Spasić [Vice-Chairman, Institute of Comparative Molecular Endocrinology]); Funded by the Excellence Initiative of the German Federal and State Governments until October 31, 2019; continued funding by the State of Baden-Württemberg and the Medical Faculty.

Initiative funded by Baden-Württemberg Foundation:

• Join the Healthy Boat - program for health promotion in kindergartens and primary schools (Speaker: Prof. Dr. J. Steinacker, Section Sports and Rehabilitation Medicine)

Cooperative Projects:

• Center Child Abuse and Neglect (Speaker: Prof. Dr. J. Fegert, Department of Child and Adolescent Psychiatry/Psychotherapy); ends December 31, 2022
• Cooperative Project Neuroinflammation in Neurodegeneration (Speaker: Prof. Dr. T. Wirth, Institute of Physiological Chemistry); successfully concluded December 31, 2021

Forum Gesundheitsstandort BW (Forum Health Location BW):

• Translation in University Medicine: Innovative Platform for improved diagnostics and cooperation with leading pharmaceutical industry (Speakers: Prof. Dr. T. Wirth, Dean; Prof. Dr. U.X. Kaisers, Leading Medical Director)

SARS-CoV-2 and Long COVID Programs:

The Medical Faculty is involved in several projects investigating SARS-CoV-2 and Long COVID under special funding program of the State of Baden-Württemberg. Among the projects newly granted in 2022 which are still running, one network is coordinated in Ulm:

• A PILOT Study – App-based exercise training intervention for Long- and Post-COVID treatment (Speaker: Prof. Dr. J. Steinacker, Section Sports and Rehabilitation Medicine)

Research Center in Public-Private Partnership:

• Boehringer Ingelheim Ulm University BioCenter (BIU 2.0). Topics: neuropsychiatric, cardio metabolic and lung diseases as well as immunmodulatory aspects (Speaker: Prof. Dr. K.-M. Debatin, Medical Faculty)

Center of Excellence in Oncology funded by the German Cancer Aid:

• Comprehensive Cancer Center Ulm (CCCU) (Speaker: Prof. Dr. St. Stilgenbauer, Department of Internal Medicine III)

Forschungskolleg funded by the Else Kröner-Fresenius-Stiftung:

• Else Kröner-Forschungskolleg: Entwicklung und Etablierung prädiktiver Modelle zur Realisierung von personalisierter Tumortherapie (Speaker: Prof. Dr. A. Kleger, Prof. Dr. T. Seufferlein, Department of Internal Medicine I)

Research Center funded by the Charcot Foundation:

• ALS Research Center (Speaker Prof. Dr. A.C. Ludolph, Department of Neurology)

Research Network funded by the CHDI Foundation:

• The Euro Huntington’s Disease Network (Speaker: Prof. Dr. B. Landwehrmeyer, Department of Neurology)

German Centers for Health Research:

• Site of DZNE - German Center for Neurodegenerative Diseases within the Helmholtz Association (Site Speaker: Prof. Dr. A.C. Ludolph, Department of Neurology)
• Site of DZKJ - German Center for Child and Adolescent Health, which is currently under development (Site Speaker: Prof. Dr. K.-M. Debatin, Department of Pediatrics and Adolescent Medicine)
• Member of "ZIHUb - Mental Health Alliance", Site of DZPG - German Center for Mental Health, which is currently under development (Coordination: ZI Mannheim; Speaker Ulm: Prof. Dr. J.M. Fegert, Department of Child and Adolescent Psychiatry/Psychotherapy)

Furthermore, Prof. Reinhard Holl (Institute of Epidemiology and Medical Biometry) is project partner in the German Center for Diabetes Research (DZD) and Prof. Ole Ammerpohl (Institute of Human Genetics) is Principal Investigator in the German Center for Lung Research (DZL).